معرفی
Dr. Perry Howard is an Associate Professor in the Department of Biochemistry and Microbiology at the University of Victoria. His research focuses on RNA processing, cellular decision-making mechanisms, and their roles in human diseases such as cancer and blindness. He leads a lab investigating the ARS2 gene's role in RNA lifecycle regulation and its implications for treatments targeting diseases like malignancy and retinal disorders. His work is supported by grants from NSERC, the Foundation Fighting Blindness, and other organizations.
- Educations: BSc from University of Waterloo; PhD from University of Toronto
Research interests include understanding how RNA processing pathways govern cell behavior and disease progression. Key areas include ARS2-mediated nonsense-mediated decay, ER stress responses, and nanoparticle-based cancer therapies. His lab has discovered critical roles of ARS2 in retinal progenitor cell development and Müller glial fate specification.
Dr. Howard’s articles highlight advancements in nanotechnology for cancer treatment, histone isoform regulation, and microRNA-based therapies. His work bridges basic science and clinical applications, emphasizing translational research for human health. Grants from NSERC and other agencies support this mission.
He mentors graduate students in areas of molecular biology and nanomedicine, contributing to interdisciplinary collaborations across the Faculty of Science. His lab is part of the Biochemistry & Microbiology department at UVic, fostering innovation in gene regulation and disease modeling.
